Demand for RSV Medication Outpaces Supply, Posing Risk to Babies

A recently approved treatment was supposed to protect babies from RSV, but demand is outpacing the supply of the medication. nirsevimab, an antibody that sticks to and prevents Respiratory Syncytial Virus from infecting cells, in July. The Centers for Disease Control and Prevention (CDC) thenthe medication for all babies either born during the RSV season or those up to eight months old entering their first RSV season, which runs from about November to March.

RSV can be a dangerous and potentially deadly disease, especially for infants; aboutThe antibody is not a treatment for RSV, since it works to prevent infection, not treat it, but it’s also not a vaccine, although it works similarly and provides short term protection for infants. The antibodies in the shot essentially fill in for the antibodies that babies can’t make yet in enough quantities to fend off the virus. Because it’s not a vaccine, it’s important that babies get the antibodies at the right time, during RSV season, to give them the best chance of avoiding infectio

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

How to avoid COVID-19, the flu and RSV this holiday seasonHealth experts are reminding people to remain diligent in protecting themselves as the holiday season approaches.
Source: WGAL - 🏆 331. / 59 Read more »

Dallas Hospitals Overwhelmed with Pediatric RSV CasesEight-month-old Nicolette Karimi spent five days in Children's Medical Center in Dallas, including two days in the pediatric intensive care unit amid a surge of pediatric RSV cases. Her ordeal began Halloween night when she struggled to breathe and was eventually diagnosed with respiratory syncytial virus, COVID, adenovirus, and rhinovirus. She was released from the hospital on November 5th.
Source: dallasnews - 🏆 18. / 71 Read more »